University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 24 of 26
Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion
NCT00880607
A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium
NCT00865202
Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age
NCT00726102
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
NCT00833898
Oral Health Care Early Intervention Project
NCT00793507
Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
NCT00736996
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
NCT00718770
The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease
NCT00829920
Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
NCT00601237
Integrated Care Program for Chronic Obstructive Pulmonary Disease
NCT01045213
Study of Adherence to Colonoscopy in Women
NCT00883545
Early Neuromuscular Electrical Stimulation For Quadriceps Muscle Activation Deficits Following Total Knee Replacement
NCT00800254
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
NCT00830635
Valproate for Mood Swings and Alcohol Use Following Head Injury
NCT01760785
Dexmedetomidine Versus Midazolam for Facilitating Extubation
NCT00744380
The Effect of Protandim on Non-alcoholic Steatohepatitis
NCT00977730
Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
NCT01112683
Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
NCT00672217
Effectiveness of Minimally Invasive Total Knee Replacement in Improving Rehabilitation and Function
NCT00710840
The Post-Operative Pain Management of Pediatric Supracondylar Elbow Fractures
NCT01328782
Compression and Cold Therapy on the Post-Operative Shoulder
NCT00703729
Analysis of Calcium Balance in Chronic Kidney Disease
NCT00974532
What Makes Exercise Feel More Difficult to Women With and Without Type 2 Diabetes
NCT00785005
Age-17 Follow-up of Home Visiting Intervention
NCT00708695
Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes
NCT00786019
Prevention of Obesity in Women Via Estradiol Regulation
NCT00687739
Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus
NCT00668954
Use of Ranibizumab With Mitomycin C During Trabeculectomy
NCT00661583
Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
NCT00974051
Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
NCT00635791
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
NCT00630734
Following Lipectomy to Understand Adipose Tissue Re-accumulation
NCT00995631
Incretin Effect in People With Impaired Fasting Glucose
NCT00795275
Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
NCT00788359
Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
NCT00561834
Fluid Resuscitation for Pediatric Diabetic Ketoacidosis
NCT01701557
Assessing Ocular Surface Changes After Changing Glaucoma Medications
NCT00554411
Intervention to Reduce Injection Drug Use
NCT00786630
Marketing Fall Prevention Classes to Older Adults in Faith-Based Congregations
NCT00542360
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
NCT00454922
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
NCT00551096
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
NCT00826904
Primary Intervention With Mucosal Insulin
NCT02620553
Energy Expenditure & Activity During & After Exercise-Induced Weight Loss
NCT00622310
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
NCT01693302
Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis
NCT01018303
Role of Macronutrient Diet Composition and Infant Metabolic Outcomes in Gestational Diabetes
NCT01719029
Using the Energy Gap to Prevent Weight Regain
NCT00429650
Myogenic and Osteogenic Responses to eXercise and Ibuprofen
NCT00462722
Fostering Healthy Futures Efficacy Trial for Preadolescent Youth in Foster Care
NCT00810056
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.